<p> One Care of Southwest Virginia offers</p><p>Educational Forum on Prescription Drug Abuse Abingdon, VA</p><p>Agenda</p><p>Activity Director: Sarah T. Melton, PharmD, BCPP, BCACP,FASCP Associate Professor of Pharmacy Practice Gatton College of Pharmacy at East Tennessee State University</p><p>September 24, 2016</p><p>Schedule Topic Learning Objectives 8:00 AM – 8:30 AM Breakfast and Registration</p><p>8:30 AM – 8:45 AM Welcome and Introductions </p><p>8:45 AM – 9:45 AM REVIVE! Naloxone Training  Describe the REVIVE! Sarah Melton, PharmD program, including lay administration of naloxone, protection from civil liability, and the safe reporting of overdoses law.  Discuss how opioid overdose emergencies happen and how to recognize them.  Describe the mechanism of action of naloxone.  Identify risk factors that may make someone more susceptible to an opioid overdose emergency.  Respond to an opioid overdose emergency with the administration of naloxone. 9:45 AM – 10:45 AM Disciplinary Actions from State  Discuss the reporting Regulatory Boards requirements for licensees Hughes Melton, MD who suspect their colleagues may be improperly prescribing.  Describe licensing boards' required approaches to pain management.  Explain how to update internal office policies and protocols to avoid disciplinary hearings.</p><p>10:45 AM – 11:00 AM BREAK</p><p>11:00 AM – 12:00 PM Safe Opioid Prescribing  Define addiction, substance Mary McMasters, MD FASAM misuse, tolerance, Co-Medical Director, Project withdrawal, and physical REMOTE dependence. Comprehensive Behavioral  Understand addiction as a Health, Fishersville, VA chronic relapsing brain disease.  Understand that there is evidence-based medical information on how to treat the disease.  Understand how to prescribe opioids as safely as possible.</p><p>12:00 PM – 1:00 PM Overview of Outpatient • Explain the rationale and Management of Opioid effectiveness of Dependence: Safety and buprenorphine and Efficacy of Buprenorphine and methadone maintenance Methadone therapy in the outpatient Sarah T. Melton, PharmD, BCPP, treatment of opioid BCACP,,FASCP dependence. Associate Professor of Pharmacy • Contrast the safety profiles Practice of buprenorphine and Gatton College of Pharmacy at methadone used in the East Tennessee State University treatment of opiate dependence. • Describe the components and role of non- pharmacological treatments for opioid dependence. • Apply clinical tools (e.g., treatment agreements, urine drug screens, pill counts, etc.) needed for an effective outpatient treatment program.</p><p>1:00 PM – 1:45 PM LUNCH</p><p>1:45 PM – 2:45 PM Prescription Monitoring  Review the history of the Program (PMP): Your Partner in development, initiation and Patient Management with utilization of the PMP in Controlled Substances Virginia. Ralph Orr  Explain the goals of the PMP. Program Director  Demonstrate how to use the OR PMP as a resource in Carolyn McKann, Deputy patient-centered care. Director Prescription Monitoring Program Department of Health Professions Richmond, VA</p><p>2:45 PM – 3:45 PM Universal Precautions in  Describe strategies Prescribing Controlled prescribers and Substances pharmacists can Hughes Melton, MD implement to minimize the risk of opioid misuse, abuse, and diversion.  Discuss red flags and warning signs of patients who intend to use or distribute opioids for nonmedical purposes.  Apply appropriate prescribing of controlled substances in clinical practice based on the CDC Prescribing Guidelines. 3:45 PM – 4:00 PM Wrap-up and Evaluation</p>